LigaChem Biosciences Inc. (KOSDAQ:141080)

South Korea flag South Korea · Delayed Price · Currency is KRW
173,700
-900 (-0.52%)
Dec 30, 2025, 3:30 PM KST
67.50%
Market Cap6.36T
Revenue (ttm)159.27B
Net Income (ttm)-25.13B
Shares Out36.41M
EPS (ttm)-690.95
PE Ration/a
Forward PE240.30
Dividendn/a
Ex-Dividend Daten/a
Volume245,027
Average Volume366,331
Open175,200
Previous Close174,600
Day's Range170,200 - 175,900
52-Week Range89,500 - 203,500
Beta0.74
RSI49.02
Earnings DateMar 20, 2026

About LigaChem Biosciences

LigaChem Biosciences Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of medicines for unmet medical needs. The company researches and develops products for various therapeutic areas, including antibiotics, anti-fibrotics, immuno-oncology, oncology; and antibody-drug conjugate (ADC) platform technology and small molecule drugs. It also sells medical device and supplies. It has a research collaboration and license agreement with AMGEN for the development and commercialization of ADCs. The company was for... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2006
Employees 170
Stock Exchange KOSDAQ
Ticker Symbol 141080
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.